Presentation is loading. Please wait.

Presentation is loading. Please wait.

Staphylococcus aureus…………quickly posed a problem

Published byCornelius Summers Modified over 8 years ago

Similar presentations

Presentation on theme: "Staphylococcus aureus…………quickly posed a problem"— Presentation transcript:

1 Staphylococcus aureus…………quickly posed a problem
Produce a B-lactamase (Penicillinase) Plasmid mediated (easily spread) Secreted into the surrounding medium Destroyed the Penicillin before it could reach the PBP’s S O S O S O

2 CH3 O O N R2 C NH S CH3 CH3 R1 N O COOH R1 R2 Oxacillin H H Cloxacillin Cl H Dicloxacillin Cl Cl Isoxazoyl Penicillins

3 If chemical modification can overcome B-lactamase activity
Maybe chemical modification can also increase spectrum of activity ?

4 NH2 O C NH S CH3 CH3 N O COOH Ampicillin

5 Aminopenicillins Modified to broaden their spectrum of activity better binding affinity to the PBP’s of Enterococci Listeria Some Gram –ve bacteria But a cost of slight decreased activity against Streptococci S. pneumonia / Group A strept Not stable to the B-lactamase produced by S. aureus Inactivated by many of the B-lactamases produced by Gram –ves (limited gram negative coverage)

6 Amino-Penicillin Amoxicillin Ampicillin Bacampicillin
First penicillins discovered to be active against gram negative rods like E. coli and H. Influenzae.

7 Amino-Penicillin Same coverage like Pen VK plus:
- Listeria monocytogenes - Enterococcus - Proteus mirabilus - E coli - H. flu

8 Amino-Penicillin Amoxicillin is more completely absorbed than Ampicillin. Serum levels are twice as high. Small amount is left in GI tract, so less diarrhea. However, more complete absorption makes it less effective for Shigella enteritis. Both have same antibacterial spectrum. Bacampicillin is more expensive and no advantage.

9 Amino-Penicillin Primarily used for: Otitis media Sinusitis Bronchitis
Urinary tract infection esp. Enterococcus Bacterial diarrhea Salmonella infection Shigella infection. H. Influenzae and E. Coli are increasingly becoming resistant.

10 Maybe if we change its structure a lot…..
…we will get even more gram negative coverage !

11 Carboxypenicillins Carbenicillin 1st penicillin developed with expanded gram –ve activity that included anti-pseudomonal activity But decreased activity against Streptococci and Enterococci Required large doses to be effective clinically too toxic to be used clinically Replaced by the next drug developed in this class…Ticarcillin

12 similar to Ampicillin wrt Streptococcal activity Enterococcal activity
Ureidopenicillins similar to Ampicillin wrt Streptococcal activity Enterococcal activity Better anti-pseudomonal activity then Ticarcillin Better Klebsiella activity then Ticarcillin (75% vs 5%) Not orally absorbed thus available only IV 3 preparations Azlocillin (no longer available) Mezlocillin (USA) Piperacillin (Canada / USA) Piperacillin is also available as a combination with a B-lactamase inhibitor to increase its spectrum of activity (Piperacillin + Tazobactam = Pip/Tazo)

13 O C NH S CH3 CH3 N O COOH Penicillin G

14 O CH3 C N NH O N C NH S CH3 O O CH3 N O COOH Piperacillin

15 5 Classes of Penicillins Natural Penicillins
Penicillin G / Penicillin V Penicillinase Resistant Penicillins Methicillin Nafcillin Isoxazoly Penicillins (Cloxacillin / Dicloxacillin / Oxacillin / Flucloxacillin) Aminopenicillins Ampicillin / Amoxicillin Carboxypenicillins Ticarcillin Ureidopenicillins Piperacillin / Mezlocillin / Azlocillin

16 Inducible Constituitive
B-lactamases Chromosomal Plasmid Inducible Constituitive High [ ] High [ ] Low [ ] TEM 1-27 SHV 1-8 OXA 1-3 PSE 1-5 SPACE Serratia Pseudomonas Acintobacter Citrobacter Enterobacter Can NOT be overcome by Can be overcome by B-lactam – B-lactamase Inhibitor B-lactam – B-lactamase Inhibitor Combinations Combinations

17 Antibiotics Biosynthetic Chemical Penicillin (1945)

18 Antibiotics Biosynthetic Chemical Penicillin (1945) Search for other Compounds Chemical Modification

19 We like to think we are smart
Chemical Manipulation

20 Bacteria have been fighting each other since before we evolved
Nature has been doing chemical modifications for millions of years There have been many chemical modifications

21 R S CH3 CH3 N O COOH B-lactam

22 R C CH3 R S CH3 CH3 CH3 N N O COOH O COOH Carbepenem B-lactam

23 Carbapenems 1st isolated from Streptomyces cattleya in 1976 Base compound was thienamycin - methylene replacement for the Sulphur in the 5 membered ring R C CH3 R S CH3 CH3 CH3 N N O COOH O COOH Carbepenem B-lactam

24 Carbapenems stable to B-lactamases due to the side chain being in a trans rather then the typical cis configuration seen in B-lactams R S R N N O O B-lactam Carbapenem

25 2 Compounds in clinical use :
Imipenem Meropenem Imipenem Meropenem

26 Imipenem Spectrum of Activity Gram +ve cocci - Staphylococcus aureus - Streptococci sp - S. pneumoniae - Enterococci Gram –ve rods - except Pseudomonas cepacia and Xanthomonas maltophilia Anaerobes - except Clostrium difficile and a % of Bacteroides sp

27 Mechanism of Action - binds to the PBP’s leading to cell lysis Considered Bacterocidal (except for Enterococcus – bacteriostatic) Resistance - not due to the typical B-lactamases 1. Enzyme that will hydrolyze the imipenem 2. Loss of an outer membrane protein that would otherwise facilitate entry

28 R S CH3 R S CH3 CH3 CH3 N N O COOH O COOH Side Chain Modifications Penicillin R C CH3 R CH3 S N R O COOH N O Carbapenem Cephalosporin COOH

29 Cephalosporins 1940’s Cephalosporium acremonium was isolated from the seawater At the harbour sewage outlet of Cagliari, Sardinia Produced a substance that inhibited the growth of both gram +ve and gram –ve bacteria 1948 a culture of the fungus C. acremonium was sent to Oxford 3 antimicrobial substances produced by this fungus were identified Cephalosporin P gram +ve activity only Cephalosporin N re-identified as a penicillin Cephalosporin C foundation for current Cephalosporin family

30 Cephalosporin C - B-lactam ring fused to a 6 membered dihyrdothiazine ring

31

32 Binds to PBP’s and interferes with synthesis of the peptidoglycan
Mechanism of Action Binds to PBP’s and interferes with synthesis of the peptidoglycan cell wall Bactericidal Stable to many B-lactamases produced by gram +ve and gram –ve’s Better ability to penetrate the outer LPS membrane of gram –ve bacteria LPS Peptidoglycan Cell membrane Gram –ve Gram +ve

33 Lipopolysaccharide (LPS)
Mechanisms of Resistance Alteration of the PBP target Production of B-lactamases that inactivate cephalosporins (Cephalinosporinases) Decreased ability of the Antibiotic to reach its target (LPS of gram –ve bacteria) PBP’s B-Lactamases Cell Memebrane Cell Wall Lipopolysaccharide (LPS)

34 Decreased affinity of PBP’s to bind cephalosporins are seen in
Streptococcus pneumoniae Haemophilus influenzae Neisseria gonorrhea MRSA Major mechanism of resistance in gram +ve bacteria

35 Cephalosporinases (serine proteases) hydrolyze the amide bond
of the B-lactam ring thus inactivating the antibiotic Major mechanism of resistance in gram –ve bacteria Can be encoded chromosomally or on plasmids Can be constitutive or inducible Effectiveness depends on Affinity of the Cephalosporinase for the Cephalosporin Concentration of the Cephalosporinase produced Concentration of the Cephalosporin present

36 Plasmid mediated B-lactamases are often produced in large numbers
Number of different classes (TEM, SHV, etc) Mutations lead to B-lactamases with increased spectrum of activity ESBL’s (Extended Spectrum B-lactamases) resistance to the 3rd generation cephalosporins also will destroy the monobactams (Aztreonam) however the Carbapenems are not affected (Imipenem / Meropenem)

37

38 Classification – based on the spectrum of activity
1st generation : gram +ve cocci 2nd generation : variable g +ve but increased gram –ve rod activity 3rd generation : variable g +ve but greatly increased g -ve activity 4th generation : g +ve and increased g -ve activity

39

40

41 1st Generation Half Life Peak Protein CSF
[ ] Bound Penetration Cephalothin (Ceporacin) IV 1hr Cefazolin (Ancef) IV 1hr Cephalexin (Keflex) po 1hr Cefadroxil (Duricef) po 1hr 2nd Generation Cefoxitin (Mefoxin) IV 0.8 hr Cefotetan (Cefotan) IV 3.5 hrs Cefuroxime (Kefurox/Ceftin) IV / po 1.3 hrs /- Cefaclor (Ceclor) po 0.8 hrs Cefprozil (Cefzil) po 1.2 hrs 3rd Generation Cefotaxime (Claforan) IV 1.0 hrs Ceftriaxone (Rocephin) IV 8 hrs Ceftizoxime (Cefizox) IV 1.7 hrs Ceftazidime (Fortaz) IV 1.8 hrs 4th Generation Cefepime (Maxipime) IV 2.1 hrs

42 1st Generation Half Life Peak [ ] Protein Bound
Cephalothin (Ceporacin) IV 1hr % Cefazolin (Ancef) IV 1hr % Cephalexin (Keflex) po 1hr % Cefadroxil (Duricef) po 1hr % What does this mean ? ….. Best 1st Generation Oral Drug is Cephalexin (Keflex) - higher peak concentration - less protein binding -- means more free drug to act on bacteria Best 1st Generation IV drug is Cefazolin (Ancef) - even though more is protein bound (80vs70%), the higher peak means.. -- more free drug to act on bacteria NO CSF Penetration thus do not use in Meningitis

43 2nd Generation Half Life Peak Protein CSF
[ ] Bound Penetration Cefoxitin (Mefoxin) IV 0.8 hr Cefotetan (Cefotan) IV 3.5 hrs Cefuroxime (Kefurox/Ceftin) IV / po 1.3 hrs 100/ /- Cefaclor (Ceclor) po 0.8 hrs Cefprozil (Cefzil) po 1.2 hrs Cefoxitin Cefuroxime Cefaclor Cefprozil

44 3rd Generation Half Life Peak Protein CSF
[ ] Bound Penetration Cefotaxime (Claforan) IV 1.0 hrs Ceftriaxone (Rocephin) IV 8 hrs Ceftizoxime (Cefizox) IV 1.7 hrs Ceftazidime (Fortaz) IV 1.8 hrs Cefixime (Suprax) po 3.5 hrs Cefotaxime Ceftriaxone

45 R S CH3 R S CH3 CH3 CH3 N N O COOH O COOH Side Chain Modifications Penicillin R C CH3 R CH3 S N R O COOH N O Carbapenem Cephalosporin COOH

46 R S CH3 R S CH3 CH3 CH3 N N O COOH O COOH Side Chain Modifications Penicillin R C CH3 R CH3 S Monobactam N R O COOH N O Carbapenem Cephalosporin COOH

47 Monobactams Isolated from Chromobacterium violaceum in 1981 Monocyclic B-lactam antibiotic No activity against gram +ve bacteria or anaerobes Binds to PBP’s of gram –ve bacteria only Hydrolyzed by cephalosporinases of Pseudomonas cepacia Xanthomonas maltophilia Acinitobacter Klebsiella oxytoca Haemophilus

48 Pharmacology no oral absorption thus available as IV formulation only Renal clearance Complications mild rash Mild transaminitis NO MAJOR SIDE EFFECTS Lack of cross reaction with other B-lactam antibiotics thus can be used in Pen/Ceph allergic patients

49 Aztrenoam monobactam in clinical use Limited to Gram –ve infections only

50 Penicillins Carbepenems Monobactams Cephalosporins B-lactamase Inhibitors Structural Overview

51 Antibiotics Biosynthetic Chemical Penicillin (1945) Search for other Compounds Chemical Modification

52 Antibiotics Biosynthetic Chemical Penicillin (1945) Search for other Compounds Chemical Modification Carbapenems Monobactams Cephalosporins Different Mechanisms B-lactam Antibiotics

53 Glycopeptides

54 1st compound was isolated from Streptomyces orientalis in 1956
Glycopeptides 1st compound was isolated from Streptomyces orientalis in 1956 (bacteria) Complex structure amino acids + sugars Vancomycin

55 Mechanism of Action : Inhibit cell wall synthesis - binds to peptidoglycan precursors - blocks additional polymer extension

56 N-acetylglucosamine N-acetylmuramic acid d-ala L-glu Lys Cell wall
Cell membrane Transpeptidases (PBP’s)

57 N-acetylglucosamine N-acetylmuramic acid d-ala L-glu Lys N-acetylglucosamine N-acetylmuramic acid d-ala L-glu Lys N-acetylglucosamine N-acetylmuramic acid d-ala L-glu Lys N-acetylglucosamine N-acetylmuramic acid d-ala L-glu Lys N-acetylglucosamine N-acetylmuramic acid d-ala L-glu Lys

58 Vancomycin blocks cell wall synthesis
N-acetylglucosamine N-acetylmuramic acid d-ala L-glu Lys Mechanism of action of Vancomycin Vancomycin blocks cell wall synthesis By binding to the d-alanyl-d-alanine site on the growing peptidoglycan chain N-acetylglucosamine N-acetylmuramic acid d-ala L-glu Lys

59 Useful drug to treat B-lactam resistant staphylococcus aureus
Vancomycin Useful drug to treat B-lactam resistant staphylococcus aureus Staphylococcus aureus No b-lactamase B-lactamase Alter PBP’s (Penicillinase) (MRSA) Penicillin Cloxacillin Vancomycin

60 Vancomycin Useful drug to treat B-lactam resistant enterococcus Enterococcus species No b-lactamase B-lactamase Alter PBP’s Ampicillin Vancomycin

61 Resistance to Vancomycin
Change in d-alanyl-d-alanine precursors - Van A, B, C mutations of VRE Excess cell wall production - VISA Biofilm production seen on prosthetic devices /foreign bodies Biofilms produced by bacteria impair the penetration of the glycopeptide to the bacterial cells Gram negatives constitutively resistant (LPS)

62 N-acetylglucosamine N-acetylmuramic acid d-ala L-glu Lys Cell wall
d-lactate Cell membrane Transpeptidases (PBP’s)

63 Mechanism of resistance
N-acetylglucosamine N-acetylmuramic acid d-ala L-glu Lys d-lactate Mechanism of resistance to Vancomycin

64 VRE Gene Complex Van H gene Van A gene Van X gene Van R & S genes
- synthesizes d-lactate Van A gene - binds d-lactate to d-alanine Van X gene - hydrolyzes d-ala-d-ala Van R & S genes - regulatory gene regions Van Y& Z genes - accessory proteins

65 Antibiotics Biosynthetic Chemical Penicillin (1945) Search for similar compounds Chemical modification

66 Biosynthetic Chemical
Antibiotics Biosynthetic Chemical B-lactam based antibiotics Penicillins Carbapenems Monobactams Cephalosporins

67 Biosynthetic Chemical
Antibiotics Biosynthetic Chemical B-lactam based antibiotics Penicillins Carbapenems Monobactams Cephalosporins Vancomycin (1956) Search for similar compounds Chemical modification

68 Naturally occuring glycopeptides
Vancomycin Streptomyces orientalis Teicoplanin (Targocid) Actinoplanes teichomyceticus Daptomycin (Cubicin) Streptomyces roseosporus Ramoplanin Actinoplanes ATCC 33076 Semisythetic glycopeptides (2nd Generation) Oritavancin Dalbavancin Telavancin

69 Glycopeptide Antibiotics
Glycopepetides Lipopeptides Lipoglycopeptides Vancomycin Teicoplanin Daptomycin (Cubicin) (LY146032) Ramoplanin Oritavancin (LY33328) Dalbavancin Telavancin Semisynthetic derivatives Inhibition of cell wall synthesis Inhibition of cell wall synthesis + Increase cell membrane permeability Cidal

70 Vancomycin Oritavancin Teicoplanin Dalbavancin

71 Role of the newer glycopeptide antibiotics….
Combat emerging resistance of MRSA VRE

72 Biosynthetic Antibiotics that inhibit protein synthesis
Lincosamides 1962 Aminoglycosides 1943 Stretpogramins 1953 Macrolides 1952 Tetracyclines 1953

Download ppt "Staphylococcus aureus…………quickly posed a problem"

Similar presentations

Beta-Lactamase Inhibitors

Beta-Lactamase Inhibitors
Pharmacology and development of Antibiotics (Penicillin) and Antiseptics 13/02/13 By: Mohit Kumar Sharma PhD Final year.

Pharmacology and development of Antibiotics (Penicillin) and Antiseptics 13/02/13 By: Mohit Kumar Sharma PhD Final year.
Antimicrobials: Drugs that Weaken the Cell Wall

Antimicrobials: Drugs that Weaken the Cell Wall
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 84 Drugs That Weaken the Bacterial Cell Wall I: Penicillins.

Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 84 Drugs That Weaken the Bacterial Cell Wall I: Penicillins.
Antibiotics.

Antibiotics.
Pharmacology-1 PHL 211 2 nd Term 10 th Lecture By Abdelkader Ashour, Ph.D. Phone: 4677212

Pharmacology-1 PHL nd Term 10 th Lecture By Abdelkader Ashour, Ph.D. Phone:
Bacterial Physiology (Micr430) Lecture 10 Macromolecular Synthesis: Cell Wall (Text Chapter: 11)

Bacterial Physiology (Micr430) Lecture 10 Macromolecular Synthesis: Cell Wall (Text Chapter: 11)
Cephalosporins B-Lactam antibiotics ( similar to penicillins) Broad spectrum Act by inhibition of cell wall synthesis Bactericidal Inactive against :

Cephalosporins B-Lactam antibiotics ( similar to penicillins) Broad spectrum Act by inhibition of cell wall synthesis Bactericidal Inactive against :
DENS 521 Clinical Dental Therapeutics

DENS 521 Clinical Dental Therapeutics
Pharmacology-1 PHL 211 2 nd Term 9 th Lecture By Abdelkader Ashour, Ph.D. Phone: 4677212

Pharmacology-1 PHL nd Term 9 th Lecture By Abdelkader Ashour, Ph.D. Phone:
CEPHALOSPORINS First used clinically in the early 1960’s. First used clinically in the early 1960’s. They have an important role in the modern treatment.

CEPHALOSPORINS First used clinically in the early 1960’s. First used clinically in the early 1960’s. They have an important role in the modern treatment.
Cephalosporins.

Cephalosporins.
2003-2004 Antibiotics Review 10 August 2015 6:39 AM.

Antibiotics Review 10 August :39 AM.
Bacterial Cell Wall Inhibitors

Bacterial Cell Wall Inhibitors
Beta-lactam antibiotics - Cephalosporins

Beta-lactam antibiotics - Cephalosporins
Β-Lactam antibiotics. Classification Penicillins Cephalosporins Other β-Lactam drugs Cephamycins （头霉素类） Carbapenems （碳青霉烯类） Oxacephalosporins （氧头孢烯类）

Β-Lactam antibiotics. Classification Penicillins Cephalosporins Other β-Lactam drugs Cephamycins （头霉素类） Carbapenems （碳青霉烯类） Oxacephalosporins （氧头孢烯类）
Gram Negative Gram Positive

Gram Negative Gram Positive
Antibiotics Bio 1220 16 February 2010 Ethan Richman Ben Kwak Ampicillin, Tetracyclin, and Chloramphenicol.

Antibiotics Bio February 2010 Ethan Richman Ben Kwak Ampicillin, Tetracyclin, and Chloramphenicol.
PENICILLINS  One of the most important groups of antibiotics.  They are still widely used.  Drugs of choice for a large number of infectious diseases.

PENICILLINS  One of the most important groups of antibiotics.  They are still widely used.  Drugs of choice for a large number of infectious diseases.
Antibacterial Inhibitors of Cell Wall Synthesis –Very high therapeutic index Low toxicity with high effectiveness β- lactam Drugs –Inhibit peptidoglycan.

Antibacterial Inhibitors of Cell Wall Synthesis –Very high therapeutic index Low toxicity with high effectiveness β- lactam Drugs –Inhibit peptidoglycan.

Similar presentations

Ads by Google